This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Hai Kang Life Corporation Limited. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2022
Title: Innovations of Cheng Chang Lai in Biochip Technology
Introduction
Cheng Chang Lai is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of biochip technology, holding a total of 2 patents. His work focuses on methods for detecting and sequencing biomolecules, which have important applications in biotechnology and medical diagnostics.
Latest Patents
Cheng Chang Lai's latest patents include innovative methods for fabricating biochips designed for the detection and sequencing of biomolecules. One of his patents describes a biochip that consists of a base member and a dielectric layer with discrete recesses. This design incorporates electrodes that create an electric field, drawing biomolecules towards specific areas of the operation surface. Another patent outlines a similar biochip structure, emphasizing the importance of the dielectric layer and the arrangement of electrodes in enhancing biomolecule detection.
Career Highlights
Cheng Chang Lai is currently associated with Hai Kang Life Corporation Limited, where he continues to advance his research in biochip technology. His work has positioned him as a key figure in the development of innovative solutions for biomolecular analysis.
Collaborations
Cheng has collaborated with notable colleagues, including Cheung Hoi Yu and Bo Liang Jia, contributing to a dynamic research environment that fosters innovation in biochip technology.
Conclusion
Cheng Chang Lai's contributions to biochip technology exemplify the intersection of innovation and practical application in the field of biotechnology. His patents reflect a commitment to advancing methods for biomolecular detection, which could have far-reaching implications in various scientific domains.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile